ADAR1 Capital Management »

Omeros Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Omeros Corporation (OMER) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Omeros Corporation

Tip: Access up to 7 years of quarterly data

All positions including Omeros Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omeros Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 100k 17.18

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Omeros Corporation

BlackRock
Vanguard Group
Ingalls & Snyder
Polar Securities
Susquehanna International
UBS Group
Stifel Financial
Geode Capital Management
State Street Corporation
Ikarian Capital
D. E. Shaw & Co
Two Sigma Investments
Nomura Holdings
Citadel Advisors
Jane Street

View all funds holding Omeros Corporation